(Q31114967)

29 June 2017

title

Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data (English)

1 reference

29 June 2017

1 reference

Paul Heath

7

0 references

Katrin Susanne Kohl

1

object named as

Katrin S Kohl

1 reference

29 June 2017

5

Scott Halperin

1 reference

29 June 2017

Wikke Walop

2

1 reference

29 June 2017

Jane Gidudu

3

1 reference

29 June 2017

Leslie Ball

4

1 reference

29 June 2017

Sandra Jo Hammer

6

1 reference

29 June 2017

Renald Hennig

8

1 reference

29 June 2017

Edward Rothstein

9

1 reference

29 June 2017

Anne Schuind

10

1 reference

29 June 2017

Frederick Varricchio

11

1 reference

29 June 2017

Brighton Collaboration Local Reactions Working Group for Induration at or near Injection Site

12

1 reference

29 June 2017

language of work or name

English

0 references

publication date

8 May 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

25

1 reference

29 June 2017

issue

31

1 reference

29 June 2017

page(s)

5839-5857

1 reference

Combined vaccination against yellow fever and typhoid fever: a comparative trial

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Dose–Response to a Two-Component Acellular Pertussis Vaccine In Infants and Comparison with Whole-cell Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Safety and immunogenicity of Haemophilus influenzae type b-tetanus toxoid conjugate, presented in a dual-chamber syringe with diphtheria-tetanus-pertussis and inactivated poliomyelitis combination vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Safety and immunogenicity of combined or associated administration of PRP-T vaccine with diphtheria, tetanus and pertussis vaccine in Thai children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

The development of standardized case definitions and guidelines for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.062

10.1016/J.VACCINE.2007.04.062

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference